Literature DB >> 19333222

Pathology: are circulating tumor cells predictive of overall survival?

Klaus Pantel1, Sabine Riethdorf.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19333222     DOI： 10.1038/nrclinonc.2009.23

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

1.  Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.

Authors:  Daniel C Danila; Glenn Heller; Gretchen A Gignac; Rita Gonzalez-Espinoza; Aseem Anand; Erika Tanaka; Hans Lilja; Lawrence Schwartz; Steven Larson; Martin Fleisher; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

2.  Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.

Authors:  R A Ghossein; J Rosai; H I Scher; M Seiden; Z F Zhang; M Sun; G Chang; K Berlane; K Krithivas; P W Kantoff
Journal:  Urology       Date:  1997-07       Impact factor: 2.649

3.  Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

Authors:  W Jeffrey Allard; Jeri Matera; M Craig Miller; Madeline Repollet; Mark C Connelly; Chandra Rao; Arjan G J Tibbe; Jonathan W Uhr; Leon W M M Terstappen
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

4.  Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.

Authors:  Robert W Ross; Judith Manola; Kristen Hennessy; Matthew Galsky; Howard Scher; Eric Small; W Kevin Kelly; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

5.  Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.

Authors:  Takatsugu Okegawa; Kikuo Nutahara; Eiji Higashihara
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

Review 6.  Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Authors:  Klaus Pantel; Ruud H Brakenhoff; Burkhard Brandt
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716

7.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor.

Authors:  Johann S de Bono; Gerhardt Attard; Alex Adjei; Michael N Pollak; Peter C Fong; Paul Haluska; Luisa Roberts; Carrie Melvin; Madeline Repollet; David Chianese; Mark Connely; Leon W M M Terstappen; Antonio Gualberto
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531
  8 in total
  21 in total

1.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Authors:  Yekaterina B Khotskaya; Benjamin H Beck; Douglas R Hurst; Zhenbo Han; Weiya Xia; Mien-Chie Hung; Danny R Welch
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

Review 2.  Rethinking the metastatic cascade as a therapeutic target.

Authors:  Lida A Mina; George W Sledge
Journal:  Nat Rev Clin Oncol       Date:  2011-04-19       Impact factor: 66.675

3.  Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis.

Authors:  Yi Liao; Shu-Yi Wang; Xiang-Yu Meng; Jie Yang; Ming-Jun Shi; Hua-Long Liu; Fang-Fang Chen; Bin Xiong
Journal:  Med Oncol       Date:  2014-11-21       Impact factor: 3.064

Review 4.  Epithelial-to-mesenchymal transitions and circulating tumor cells.

Authors:  Arnaud Bonnomet; Anne Brysse; Anthony Tachsidis; Mark Waltham; Erik W Thompson; Myriam Polette; Christine Gilles
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-07       Impact factor: 2.673

5.  ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood.

Authors:  Vishal Gupta; Insiya Jafferji; Miguel Garza; Vladislava O Melnikova; David K Hasegawa; Ronald Pethig; Darren W Davis
Journal:  Biomicrofluidics       Date:  2012-06-27       Impact factor: 2.800

6.  Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.

Authors:  Bee Luan Khoo; Gianluca Grenci; Ying Bena Lim; Soo Chin Lee; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

Review 7.  [Translational research and diagnostics for breast cancer].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 8.  [Beyond staging, typing and grading. New challenges in breast cancer pathology].

Authors:  H H Kreipe; P Ahrens; M Christgen; U Lehmann; F Länger
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

9.  Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.

Authors:  M Craig Miller; Gerald V Doyle; Leon W M M Terstappen
Journal:  J Oncol       Date:  2009-12-09       Impact factor: 4.375

10.  Tumor biology and cancer therapy - an evolving relationship.

Authors:  Thomas Seufferlein; Johann Ahn; Denis Krndija; Ulrike Lother; Guido Adler; Götz von Wichert
Journal:  Cell Commun Signal       Date:  2009-08-13       Impact factor: 5.712
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.